Skip to main content
. 2018 Jul 5;8:10212. doi: 10.1038/s41598-018-28395-w

Figure 2.

Figure 2

(a) Representative spectra of chondroitin sulfate proteoglycan 5B (CSPG5B). (b) Distribution of phosphorylated residues in control, EE2 and LNG treatments. (c) Distribution of phosphorylated proteins identified in the enriched fraction with 90% peptide confidence and 95% protein confidence.